Search - tctmd.com

Displaying 41 - 60 of 1777

Sort: Relevancy | Date

Presentation TCT 2025

Earlier Detection of Valvular Heart Disease

Presenter: Pierre Elias

October 26, 2025

Presentation TCT 2025

Addressing Disparities In Aortic Stenosis Management: Have We Made Progress?

Presenter: Wayne Batchelor

October 26, 2025

Presentation TCT 2025

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

Presenter: Sammy Elmariah

October 26, 2025

Presentation TCT 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Marvin H. Eng

October 26, 2025

Presentation TCT 2025

Can We Improve TAVR Durability Today? Imaging-based Procedural Solutions

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation TCT 2025

Cath Lab Quality Metrics and AUC: Measuring What Matters

Presenter: James B. Hermiller

October 26, 2025

Presentation TCT 2025

Can We Delay AS Progression Tomorrow: Pharmacological Therapy

Presenter: Philippe Pibarot

October 26, 2025

Presentation TCT 2025

Avoiding Denials and Optimizing Reimbursement in the Cath Lab

Presenter: Larry S. Dean

October 26, 2025

Presentation TCT 2025

Implications for TAVR-First or SAVR - First Strategies

Presenter: Mayra Guerrero

October 26, 2025

Presentation TCT 2025

Coding the Future: Understanding 2026 CPT Revisions and Their Impact on Practice & Reimbursement

Presenter: Arnold Seto

October 26, 2025

Presentation TCT 2025

PRO – SURGERY: 3 Reasons why Surgery is the Best Option for this Patient

Presenter: Rishi Puri

October 26, 2025

Presentation TCT 2025

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Presenter: Michael J. Reardon

October 26, 2025

Presentation TCT 2025

Coding and Documentation Essentials for Coronary and Peripheral Procedures

Presenter: Andrew Michael Goldsweig

October 26, 2025

Presentation TCT 2025

Case Presentation:

Presenter: Pier Pasquale Leone

October 26, 2025

Presentation TCT 2025

Cath Lab Economics 101: Understanding RVUs, DRGs, and Payer Trends

Presenter: Partha Sardar

October 26, 2025

Presentation TCT 2025

Aortic Valve Replacement Today: International Guidelines and Current Trends

Presenter: Fabien Praz

October 26, 2025

Presentation TCT 2025

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Presenter: Santiago Garcia

October 25, 2025

Presentation TCT 2025

Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial

Presenter: Thomas Elie Modine

October 25, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

Presentation TCT 2025

Power in Partnership: Why I Champion the Cardiovascular Team

Presenter: David J. Cohen

October 25, 2025

Advertisement

Earlier Detection of Valvular Heart Disease

Addressing Disparities In Aortic Stenosis Management: Have We Made Progress?

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Can We Improve TAVR Durability Today? Imaging-based Procedural Solutions

Cath Lab Quality Metrics and AUC: Measuring What Matters

Can We Delay AS Progression Tomorrow: Pharmacological Therapy

Avoiding Denials and Optimizing Reimbursement in the Cath Lab

Implications for TAVR-First or SAVR - First Strategies

Coding the Future: Understanding 2026 CPT Revisions and Their Impact on Practice & Reimbursement

PRO – SURGERY: 3 Reasons why Surgery is the Best Option for this Patient

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Coding and Documentation Essentials for Coronary and Peripheral Procedures

Case Presentation:

Cath Lab Economics 101: Understanding RVUs, DRGs, and Payer Trends

Aortic Valve Replacement Today: International Guidelines and Current Trends

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Power in Partnership: Why I Champion the Cardiovascular Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content